Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Abstract Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.

Bibliographic Details
Main Authors:	Irina Nordkin, Tatyana Levinas, Inna Rosenfeld, Majdi Halabi
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Clinical Case Reports
Subjects:	amiodarone atrial fibrillation QT prolongation torsades de Pointes
Online Access:	https://doi.org/10.1002/ccr3.3539

id	doaj-d301dd021bfc46e28df183f3ecc16d17
record_format	Article
spelling	doaj-d301dd021bfc46e28df183f3ecc16d172021-05-21T11:05:45ZengWileyClinical Case Reports2050-09042021-01-019139139410.1002/ccr3.3539Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillationIrina Nordkin0Tatyana Levinas1Inna Rosenfeld2Majdi Halabi3Ziv Medical Center Cardiology Department Tzfat IsraelThe Azrieli Faculty of Medicine Bar‐Ilan University IsraelZiv Medical Center Cardiology Department Tzfat IsraelZiv Medical Center Cardiology Department Tzfat IsraelAbstract Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.https://doi.org/10.1002/ccr3.3539amiodaroneatrial fibrillationQT prolongationtorsades de Pointes
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Irina Nordkin Tatyana Levinas Inna Rosenfeld Majdi Halabi
spellingShingle	Irina Nordkin Tatyana Levinas Inna Rosenfeld Majdi Halabi Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation Clinical Case Reports amiodarone atrial fibrillation QT prolongation torsades de Pointes
author_facet	Irina Nordkin Tatyana Levinas Inna Rosenfeld Majdi Halabi
author_sort	Irina Nordkin
title	Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_short	Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_full	Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_fullStr	Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_full_unstemmed	Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_sort	torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
publisher	Wiley
series	Clinical Case Reports
issn	2050-0904
publishDate	2021-01-01
description	Abstract Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.
topic	amiodarone atrial fibrillation QT prolongation torsades de Pointes
url	https://doi.org/10.1002/ccr3.3539
work_keys_str_mv	AT irinanordkin torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation AT tatyanalevinas torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation AT innarosenfeld torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation AT majdihalabi torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation
_version_	1721432132568481792

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Similar Items